MetaADEDB 2.0 @ LMMD
estradiol 17 beta-cypionate
(UOACKFBJUYNSLK-XRKIENNPSA-N)
Structure
SMILES
O=C(O[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCc2c1ccc(c2)O)CCC1CCCC1
Type(s)
Approved; Investigational; Vet_approved
Molecular Formula:
C26H36O3
Molecular Weight:
396.562
Log P:
6.1305
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
1
TPSA:
46.53
CAS Number(s):
313-06-4
Synonym(s)
1.
estradiol 17 beta-cypionate
2.
Depo-estradiol
3.
estradiol 17 beta-cyclopentylpropionate
4.
estradiol cypionate
External Link(s)
MeSHC007630
PubChem Compound9403
ChEBI34745
CHEMBLCHEMBL1200973
DrugBankDB13954
DrugCentral1059
KEGGcpd:C14640
dr:D04063
ZINC3876078
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 20OFFSIDES
US FAERS
2Product quality issueFAERS: 6US FAERS
3HeadacheFAERS: 5US FAERS
4Poor quality drug administeredFAERS: 5OFFSIDES
US FAERS
5AstheniaFAERS: 4OFFSIDES
US FAERS
6Injection site abscessFAERS: 4US FAERS
7MalaiseFAERS: 4US FAERS
8Burning sensationFAERS: 3US FAERS
9DizzinessFAERS: 3US FAERS
10FatigueFAERS: 3US FAERS
11Mood swingsFAERS: 3US FAERS
12Product use issueFAERS: 3US FAERS
13PruritusFAERS: 3US FAERS
14TremorFAERS: 3US FAERS
15Anaphylactic shockFAERS: 2US FAERS
16BlindnessFAERS: 2US FAERS
17Cerebrovascular accidentFAERS: 2US FAERS
18Cold sweatFAERS: 2US FAERS
19Drug ineffective for unapproved indicationFAERS: 2US FAERS
20Drug withdrawal syndromeFAERS: 2US FAERS
21DysgeusiaFAERS: 2US FAERS
22Feeling ColdFAERS: 2US FAERS
23NauseaFAERS: 2US FAERS
24PneumonectomyFAERS: 2OFFSIDES
US FAERS
25Product storage errorFAERS: 2US FAERS
26SinusitisFAERS: 2US FAERS
27Skin necrosisFAERS: 2OFFSIDES
US FAERS
28Staphylococcal abscessFAERS: 2OFFSIDES
US FAERS
29Subcutaneous AbscessFAERS: 2OFFSIDES
US FAERS
30Therapeutic response unexpectedFAERS: 2US FAERS
31Abdominal discomfortFAERS: 1OFFSIDES
US FAERS
32AbscessFAERS: 1OFFSIDES
US FAERS
33AmnesiaFAERS: 1OFFSIDES
US FAERS
34ArthralgiaFAERS: 1US FAERS
35ArthritisFAERS: 1US FAERS
36AsthmaFAERS: 1US FAERS
37Autoimmune thyroiditisFAERS: 1US FAERS
38Back PainFAERS: 1US FAERS
39Blood cholesterol increasedFAERS: 1US FAERS
40Blood thyroid stimulating hormone decreasedFAERS: 1US FAERS
41Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
42Bone painFAERS: 1US FAERS
43Chest PainFAERS: 1OFFSIDES
US FAERS
44Drug dose omissionFAERS: 1US FAERS
45Drug effect incompleteFAERS: 1US FAERS
46EpistaxisFAERS: 1US FAERS
47Expired product administeredFAERS: 1US FAERS
48Facial PainFAERS: 1US FAERS
49Feeling abnormalFAERS: 1OFFSIDES
US FAERS
50Feeling jitteryFAERS: 1US FAERS
51Head discomfortFAERS: 1US FAERS
52Hepatitis CFAERS: 1US FAERS
53HypersensitivityFAERS: 1US FAERS
54HypothyroidismFAERS: 1US FAERS
55Impaired gastric emptyingFAERS: 1US FAERS
56InflammationFAERS: 1US FAERS
57InfluenzaFAERS: 1US FAERS
58Injection site erythemaFAERS: 1US FAERS
59Injection site irritationFAERS: 1US FAERS
60Injection site massFAERS: 1US FAERS
61Injection site noduleFAERS: 1US FAERS
62Intentional product misuseFAERS: 1US FAERS
63Macular degenerationFAERS: 1US FAERS
64MyalgiaFAERS: 1US FAERS
65Neck PainFAERS: 1US FAERS
66NephrolithiasisFAERS: 1US FAERS
67NervousnessFAERS: 1US FAERS
68Night sweatsFAERS: 1US FAERS
69Pharmaceutical product complaintFAERS: 1US FAERS
70PneumoniaFAERS: 1US FAERS
71Poor quality product administeredFAERS: 1US FAERS
72Poor quality sleepFAERS: 1US FAERS
73Pre-existing condition improvedFAERS: 1US FAERS
74Product physical consistency issueFAERS: 1US FAERS
75Product physical issueFAERS: 1US FAERS
76Product prescribing errorFAERS: 1US FAERS
77SwellingFAERS: 1US FAERS
78ThrombosisFAERS: 1US FAERS
79UrticariaFAERS: 1US FAERS
80Accidental overdoseOFFSIDES
81Acid refluxOFFSIDES
82Acute myocardial infarctionOFFSIDES
83Adverse eventOFFSIDES
84AlopeciaOFFSIDES
85Androgens decreasedOFFSIDES
86AngerOFFSIDES
87AnhidrosisOFFSIDES
88Anorexia3610789CTD
89Aortic bypassOFFSIDES
90Blood pH increasedOFFSIDES
91Blurred visionOFFSIDES
92BradycardiaOFFSIDES
93BruxismOFFSIDES
94Carotid bruitOFFSIDES
95Caustic injuryOFFSIDES
96Chronic Obstructive Airway DiseaseOFFSIDES
97Circumstance or information capable of leading to medication errorOFFSIDES
98Conjunctival depositOFFSIDES
99Corneal erosionOFFSIDES
100CryingOFFSIDES
101DehydrationOFFSIDES
102DemyelinationOFFSIDES
103Drug toxicityOFFSIDES
104Economic problemOFFSIDES
105Ejection Fraction DecreasedOFFSIDES
106EndometriosisOFFSIDES
107Febrile infectionOFFSIDES
108FibromyalgiaOFFSIDES
109Infectious MononucleosisOFFSIDES
110Intervertebral Disc DegenerationOFFSIDES
111Jugular vein distensionOFFSIDES
112Kidney FailureOFFSIDES
113Left ventricular end-diastolic pressure increasedOFFSIDES
114Lethargy3610789CTD
115Multi-organ disorderOFFSIDES
116Musculoskeletal PainOFFSIDES
117OrthopneaOFFSIDES
118PainOFFSIDES
119PancreatitisOFFSIDES
120Pharyngolaryngeal PainOFFSIDES
121Productive CoughOFFSIDES
122Pyoderma GangrenosumOFFSIDES
123RalesOFFSIDES
124Renal tubular necrosisOFFSIDES
125Respiratory FailureOFFSIDES
126Synovial CystOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.